
The global Melphalan Hydrochloride API market was valued at US$ 270 million in 2023 and is anticipated to reach US$ 405.7 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Melphalan Hydrochloride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melphalan Hydrochloride API.
Report Scope
The Melphalan Hydrochloride API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melphalan Hydrochloride API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melphalan Hydrochloride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AUROBINDO PHARMA LTD
GRANULES INDIA LTD
NAVINTA LLC
HETERO LABS LTD
SHILPA MEDICARE LTD
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
NERPHARMA SRL
FARMABIOS SPA
EMCURE PHARMACEUTICALS LTD
OLON SPA
Segment by Type
±Ê³Ü°ù¾±³Ù²â≥98%
Purity<98%
Segment by Application
Injection
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Melphalan Hydrochloride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Melphalan Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Melphalan Hydrochloride API Market Overview
1.1 Product Overview and Scope of Melphalan Hydrochloride API
1.2 Melphalan Hydrochloride API Segment by Type
1.2.1 Global Melphalan Hydrochloride API Market Value Comparison by Type (2024-2030)
1.2.2 ±Ê³Ü°ù¾±³Ù²â≥98%
1.2.3 Purity<98%
1.3 Melphalan Hydrochloride API Segment by Application
1.3.1 Global Melphalan Hydrochloride API Market Value by Application: (2024-2030)
1.3.2 Injection
1.3.3 Others
1.4 Global Melphalan Hydrochloride API Market Size Estimates and Forecasts
1.4.1 Global Melphalan Hydrochloride API Revenue 2019-2030
1.4.2 Global Melphalan Hydrochloride API Sales 2019-2030
1.4.3 Global Melphalan Hydrochloride API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Melphalan Hydrochloride API Market Competition by Manufacturers
2.1 Global Melphalan Hydrochloride API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Melphalan Hydrochloride API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Melphalan Hydrochloride API Average Price by Manufacturers (2019-2024)
2.4 Global Melphalan Hydrochloride API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Melphalan Hydrochloride API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Melphalan Hydrochloride API, Product Type & Application
2.7 Melphalan Hydrochloride API Market Competitive Situation and Trends
2.7.1 Melphalan Hydrochloride API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Melphalan Hydrochloride API Players Market Share by Revenue
2.7.3 Global Melphalan Hydrochloride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Melphalan Hydrochloride API Retrospective Market Scenario by Region
3.1 Global Melphalan Hydrochloride API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Melphalan Hydrochloride API Global Melphalan Hydrochloride API Sales by Region: 2019-2030
3.2.1 Global Melphalan Hydrochloride API Sales by Region: 2019-2024
3.2.2 Global Melphalan Hydrochloride API Sales by Region: 2025-2030
3.3 Global Melphalan Hydrochloride API Global Melphalan Hydrochloride API Revenue by Region: 2019-2030
3.3.1 Global Melphalan Hydrochloride API Revenue by Region: 2019-2024
3.3.2 Global Melphalan Hydrochloride API Revenue by Region: 2025-2030
3.4 North America Melphalan Hydrochloride API Market Facts & Figures by Country
3.4.1 North America Melphalan Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Melphalan Hydrochloride API Sales by Country (2019-2030)
3.4.3 North America Melphalan Hydrochloride API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Melphalan Hydrochloride API Market Facts & Figures by Country
3.5.1 Europe Melphalan Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Melphalan Hydrochloride API Sales by Country (2019-2030)
3.5.3 Europe Melphalan Hydrochloride API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Melphalan Hydrochloride API Market Facts & Figures by Country
3.6.1 Asia Pacific Melphalan Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Melphalan Hydrochloride API Sales by Country (2019-2030)
3.6.3 Asia Pacific Melphalan Hydrochloride API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Melphalan Hydrochloride API Market Facts & Figures by Country
3.7.1 Latin America Melphalan Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Melphalan Hydrochloride API Sales by Country (2019-2030)
3.7.3 Latin America Melphalan Hydrochloride API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Melphalan Hydrochloride API Market Facts & Figures by Country
3.8.1 Middle East and Africa Melphalan Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Melphalan Hydrochloride API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Melphalan Hydrochloride API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Melphalan Hydrochloride API Sales by Type (2019-2030)
4.1.1 Global Melphalan Hydrochloride API Sales by Type (2019-2024)
4.1.2 Global Melphalan Hydrochloride API Sales by Type (2025-2030)
4.1.3 Global Melphalan Hydrochloride API Sales Market Share by Type (2019-2030)
4.2 Global Melphalan Hydrochloride API Revenue by Type (2019-2030)
4.2.1 Global Melphalan Hydrochloride API Revenue by Type (2019-2024)
4.2.2 Global Melphalan Hydrochloride API Revenue by Type (2025-2030)
4.2.3 Global Melphalan Hydrochloride API Revenue Market Share by Type (2019-2030)
4.3 Global Melphalan Hydrochloride API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Melphalan Hydrochloride API Sales by Application (2019-2030)
5.1.1 Global Melphalan Hydrochloride API Sales by Application (2019-2024)
5.1.2 Global Melphalan Hydrochloride API Sales by Application (2025-2030)
5.1.3 Global Melphalan Hydrochloride API Sales Market Share by Application (2019-2030)
5.2 Global Melphalan Hydrochloride API Revenue by Application (2019-2030)
5.2.1 Global Melphalan Hydrochloride API Revenue by Application (2019-2024)
5.2.2 Global Melphalan Hydrochloride API Revenue by Application (2025-2030)
5.2.3 Global Melphalan Hydrochloride API Revenue Market Share by Application (2019-2030)
5.3 Global Melphalan Hydrochloride API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AUROBINDO PHARMA LTD
6.1.1 AUROBINDO PHARMA LTD Corporation Information
6.1.2 AUROBINDO PHARMA LTD Description and Business Overview
6.1.3 AUROBINDO PHARMA LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AUROBINDO PHARMA LTD Melphalan Hydrochloride API Product Portfolio
6.1.5 AUROBINDO PHARMA LTD Recent Developments/Updates
6.2 GRANULES INDIA LTD
6.2.1 GRANULES INDIA LTD Corporation Information
6.2.2 GRANULES INDIA LTD Description and Business Overview
6.2.3 GRANULES INDIA LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GRANULES INDIA LTD Melphalan Hydrochloride API Product Portfolio
6.2.5 GRANULES INDIA LTD Recent Developments/Updates
6.3 NAVINTA LLC
6.3.1 NAVINTA LLC Corporation Information
6.3.2 NAVINTA LLC Description and Business Overview
6.3.3 NAVINTA LLC Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 NAVINTA LLC Melphalan Hydrochloride API Product Portfolio
6.3.5 NAVINTA LLC Recent Developments/Updates
6.4 HETERO LABS LTD
6.4.1 HETERO LABS LTD Corporation Information
6.4.2 HETERO LABS LTD Description and Business Overview
6.4.3 HETERO LABS LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HETERO LABS LTD Melphalan Hydrochloride API Product Portfolio
6.4.5 HETERO LABS LTD Recent Developments/Updates
6.5 SHILPA MEDICARE LTD
6.5.1 SHILPA MEDICARE LTD Corporation Information
6.5.2 SHILPA MEDICARE LTD Description and Business Overview
6.5.3 SHILPA MEDICARE LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SHILPA MEDICARE LTD Melphalan Hydrochloride API Product Portfolio
6.5.5 SHILPA MEDICARE LTD Recent Developments/Updates
6.6 BIOPHORE INDIA PHARMACEUTICALS PVT LTD
6.6.1 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Corporation Information
6.6.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Description and Business Overview
6.6.3 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Melphalan Hydrochloride API Product Portfolio
6.6.5 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Recent Developments/Updates
6.7 NERPHARMA SRL
6.6.1 NERPHARMA SRL Corporation Information
6.6.2 NERPHARMA SRL Description and Business Overview
6.6.3 NERPHARMA SRL Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NERPHARMA SRL Melphalan Hydrochloride API Product Portfolio
6.7.5 NERPHARMA SRL Recent Developments/Updates
6.8 FARMABIOS SPA
6.8.1 FARMABIOS SPA Corporation Information
6.8.2 FARMABIOS SPA Description and Business Overview
6.8.3 FARMABIOS SPA Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 FARMABIOS SPA Melphalan Hydrochloride API Product Portfolio
6.8.5 FARMABIOS SPA Recent Developments/Updates
6.9 EMCURE PHARMACEUTICALS LTD
6.9.1 EMCURE PHARMACEUTICALS LTD Corporation Information
6.9.2 EMCURE PHARMACEUTICALS LTD Description and Business Overview
6.9.3 EMCURE PHARMACEUTICALS LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 EMCURE PHARMACEUTICALS LTD Melphalan Hydrochloride API Product Portfolio
6.9.5 EMCURE PHARMACEUTICALS LTD Recent Developments/Updates
6.10 OLON SPA
6.10.1 OLON SPA Corporation Information
6.10.2 OLON SPA Description and Business Overview
6.10.3 OLON SPA Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 OLON SPA Melphalan Hydrochloride API Product Portfolio
6.10.5 OLON SPA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Melphalan Hydrochloride API Industry Chain Analysis
7.2 Melphalan Hydrochloride API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Melphalan Hydrochloride API Production Mode & Process
7.4 Melphalan Hydrochloride API Sales and Marketing
7.4.1 Melphalan Hydrochloride API Sales Channels
7.4.2 Melphalan Hydrochloride API Distributors
7.5 Melphalan Hydrochloride API Customers
8 Melphalan Hydrochloride API Market Dynamics
8.1 Melphalan Hydrochloride API Industry Trends
8.2 Melphalan Hydrochloride API Market Drivers
8.3 Melphalan Hydrochloride API Market Challenges
8.4 Melphalan Hydrochloride API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
AUROBINDO PHARMA LTD
GRANULES INDIA LTD
NAVINTA LLC
HETERO LABS LTD
SHILPA MEDICARE LTD
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
NERPHARMA SRL
FARMABIOS SPA
EMCURE PHARMACEUTICALS LTD
OLON SPA
Ìý
Ìý
*If Applicable.
